ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ORIC Oric Pharmaceuticals Inc

8.08
-0.69 (-7.87%)
After Hours
Last Updated: 16:34:50
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Oric Pharmaceuticals Inc ORIC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.69 -7.87% 8.08 16:34:50
Open Price Low Price High Price Close Price Prev Close
8.79 8.07 8.801 8.08 8.77
more quote information »

Recent News

Date Time Source Heading
4/15/202416:15GLOBEORIC Pharmaceuticals Announces First Patients Dosed Across..
4/08/202408:00GLOBEORIC Pharmaceuticals Presents Preclinical Data on Two..
4/05/202416:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
4/04/202416:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
3/11/202417:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
3/11/202416:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/11/202416:10EDGAR2Form 8-K - Current report
3/11/202416:05GLOBEORIC Pharmaceuticals Reports Fourth Quarter and Full Year..
3/06/202416:30GLOBEORIC Pharmaceuticals to Present at the Leerink..
3/05/202416:30GLOBEORIC Pharmaceuticals Announces Multiple Presentations at the..
3/01/202416:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
2/14/202416:30GLOBEORIC Pharmaceuticals to Participate in the Citi 2024 Virtual..
2/05/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/02/202416:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
1/31/202416:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
1/26/202416:58EDGAR2Form S-3 - Registration statement under Securities Act of..
1/25/202413:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/22/202409:01EDGAR2Form 8-K - Current report
1/22/202408:30GLOBEORIC Pharmaceuticals Announces $125 Million Private..
1/09/202409:00EDGAR2Form 8-K - Current report
1/08/202408:30GLOBEORIC Pharmaceuticals Provides Initial Phase 1b Data for..
1/02/202416:30GLOBEORIC Pharmaceuticals to Present at the 42nd Annual J.P...
12/15/202316:32EDGAR2Form S-3 - Registration statement under Securities Act of..
12/11/202316:05EDGAR2Form 8-K - Current report
12/11/202312:00GLOBEInitial Phase 1 Dose Escalation Data for ORIC-533 in..
12/01/202316:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
11/09/202316:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
11/06/202316:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202316:10EDGAR2Form 8-K - Current report
11/06/202316:10GLOBEORIC Pharmaceuticals Reports Third Quarter 2023 Financial..
11/03/202316:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
11/02/202309:00GLOBEORIC Pharmaceuticals to Present Initial Phase 1b Clinical..
10/23/202316:07EDGAR2Form 8-K - Current report
10/21/202307:30GLOBEInitial Phase 1 Dose Escalation Data of ORIC-114 in Patients..
10/17/202316:30GLOBEORIC Pharmaceuticals to Present Initial Phase 1b Clinical..
10/06/202316:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
9/20/202316:30GLOBEORIC Pharmaceuticals to Participate in the 2023 Cantor..
9/01/202316:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
8/30/202316:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
8/10/202316:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:11EDGAR2Form 8-K - Current report
8/10/202316:05GLOBEORIC Pharmaceuticals Reports Second Quarter 2023 Financial..
8/04/202316:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
7/07/202316:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
6/26/202308:30GLOBEORIC Pharmaceuticals Announces $85 Million Private Placement..
6/02/202316:15GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
5/31/202316:10GLOBEORIC Pharmaceuticals to Participate in the Jefferies..
5/08/202316:05GLOBEORIC Pharmaceuticals Reports First Quarter 2023 Financial..
5/05/202316:15GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
4/25/202316:30GLOBEORIC Pharmaceuticals to Participate in the H.C. Wainwright..

Your Recent History

Delayed Upgrade Clock